Literature DB >> 22820072

Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Jodi K Craigo1, Corin Ezzelarab, Ronald C Montelaro.   

Abstract

A faster semi-automated 96-well microtiter plate assay to determine viral infectivity titers, or viral focal units (vfu), of equine infectious anemia virus (EIAV) stocks is described. Optimization of the existing method modernizes a classic virological technique for viral titer determination by quantitating EIAV in experimentally infected cells via a cell-based ELISA. To allow for automation, multiple parameters of the current assay procedures were modified resulting in an assay that required only one quarter the original amount of virus and/or serum for infectivity or neutralization assays, respectively. Equivalent reductions in the required volumes of tissue culture, cell processing, and protein detection reagents were also achieved. Additionally, the new assay decreased the time required from start to finish from 10 days to 6 days (viral titer) or 7 days (viral neutralization), while increasing the number of samples that can be processed concurrently by transition to a 96-well microtiter plate format and by automated counting.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820072      PMCID: PMC3474874          DOI: 10.1016/j.jviromet.2012.07.007

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  27 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV).

Authors:  P M Rwambo; C J Issel; K A Hussain; R C Montelaro
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Studies on equine infectious anemia virus transmission by insects.

Authors:  C J Issel; L D Foil
Journal:  J Am Vet Med Assoc       Date:  1984-02-01       Impact factor: 1.936

5.  Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs.

Authors:  Y Kono; K Hirasawa; Y Fukunaga; T Taniguchi
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1976

6.  C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.

Authors:  Cheng-Gang Jiang; Xu Gao; Jian Ma; Yue-Zhi Lin; Xue-Feng Wang; Li-Ping Zhao; Yue-Ping Hua; Di Liu; Jian-Hua Zhou
Journal:  Virus Res       Date:  2011-04-22       Impact factor: 3.303

7.  Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.

Authors:  Jodi K Craigo; Caroline Leroux; Laryssa Howe; Jonathan D Steckbeck; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

8.  Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli.

Authors:  S L Payne; K Rushlow; B R Dhruva; C J Issel; R C Montelaro
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

Review 9.  Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?

Authors:  Caroline Leroux; Jean-Luc Cadoré; Ronald C Montelaro
Journal:  Vet Res       Date:  2004 Jul-Aug       Impact factor: 3.683

10.  Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Authors:  Laryssa Howe; Caroline Leroux; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  2 in total

1.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

2.  Envelope determinants of equine lentiviral vaccine protection.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Liu Chong; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.